This study looks at how well and how safe a medicine called Halneuron (HAL) is for treating neuropathic pain caused by chemotherapy. Neuropathic pain is a hurting feeling that happens when nerves are damaged, and chemotherapy is a treatment usually used to kill cancer cells. In this study, participants will get a single shot under the skin (called subcutaneous injection) of HAL. To join, you must be 18 or older and have pain due to specific cancer drugs called platinum or taxane. People who have pain from other causes or have taken HAL before can't join.

• Study Duration: You will receive only one injection, but follow-up visits may be required.
• Number of Visits: Expect several visits to the study center to check your health and the effects of the treatment.
• Risks and Benefits: You may experience side effects, but the study aims to help with pain relief.

This study is randomized, meaning some people might not receive HAL but a placebo, which is a dummy treatment. Talk to your doctor if you're interested in participating.